Results 211 to 220 of about 129,354 (289)

Evaluation of dry eye syndrome in patients with obstructive sleep apnea syndrome based on serum hypoxia-inducible factor 1 alpha (HIF-1α), matrix metalloproteinase 2 (MMP-2), and desmosine levels. [PDF]

BMC Ophthalmol
Okutucu M, Sağır B, Şahin Ü, Arpa M, Yılmaz E, Uzun F, Fındık H, Kaim M, Halili E.   +8 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Empowering vision: the impact of nursing-led educational program on patients with dry eye syndrome. [PDF]

BMC Nurs
Rabie EAEGA, ElRazkey JY, Ahmed HA.
europepmc   +1 more source

Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review

Drug and Alcohol Review, Volume 45, Issue 4, May 2026.
ABSTRACT Issues Higher delta‐9‐tetrahydrocannabinol (THC) concentration medicinal cannabis products are characterised by a higher THC and minimal cannabidiol (CBD) content. This rapid review aims to systematically summarise and evaluate the available evidence regarding the efficacy and safety of higher THC potency medicinal cannabis products relevant ...
Myfanwy Graham, Dereje Assefa, Ngo Cong‐Lem, Suzanne Nielsen   +3 more
wiley   +1 more source

Nanomedicines for Dry Eye Syndrome: Targeting Oxidative Stress with Modern Nanomaterial Strategies. [PDF]

Molecules
Krawczyk A, Stadler SM, Strzalka-Mrozik B.   +2 more
europepmc   +1 more source

Repurposing Alzheimer's disease medications-systemic cholinesterase inhibitors-for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration. [PDF]

Ther Adv Ophthalmol
Rajagopal S, Ahuja P, Quach V, Luong C, Raji MA.   +4 more
europepmc   +1 more source

Quality of Life and Symptomatology in Neuropathic Corneal Pain in Comparison With Dry Eye Syndrome. [PDF]

Cornea
Chin JY, Tong L, Liu C, Lee IXY, Wong JHF, Wong RKT, Mehta JS, Liu YC.   +7 more
europepmc   +1 more source

Construction and Validation of an Educational Technology to Promote the Health of Postmenopausal Women with Dry Eye Syndrome. [PDF]

Eur J Investig Health Psychol Educ
de Almeida Junior ÁD, Bezerra IMP, Alves SAA, Tristan-Cheever E, Salati T, Abreu LC.   +5 more
europepmc   +1 more source

Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training [PDF]

, 2020
Boysen Osborn, Megan, Brinley Rajagopal, Alaina, Sudario, Gabriel, Weiland, David   +3 more
core  

The Assessment of Dry Eye Syndrome in Relation to the Use of Contact Lenses in the Jazan Region of Saudi Arabia: A Cross-Sectional Study. [PDF]

Cureus
Abusageah F, Alhazmi E, Otayf B, Zogel T, Alharbi W, Hakami F, Abulqusim E, Manni R, Moafa H, Dighriri IM, Alagsam A.   +10 more
europepmc   +1 more source